Sa-nguanmoo, Piangkwan

Personal Information

Position: Lecturer
Research areas:
Description:

āļ­.āļ”āļĢ.āļāļ .āđ€āļžāļĩāļĒāļ‡āļ‚āļ§āļąāļ āļŠāļ‡āļ§āļ™āļŦāļĄāļđāđˆ

Phone : 0-5394-9291
Email : piangkwan.s@cmu.ac.th

 

Publications

  • Sa-nguanmoo, P., Chuatrakoon, B., Parameyong, A., Jaisamer, K., Panyakum, M. & Suriyawong, W. (2024). Comparing the 6-minute Walk Test Performance and Estimated Maximal Oxygen Consumption Between Physically Active and Inactive Obese Young Adults. Physical Activity and Health, 8(1), 20 – 28. [More] 
  • Chuatrakoon, B., Konghakote, S., Sa-nguanmoo, P. & Nantakool, S. (2023). Long-term impact of SARS-CoV-2 infection on cardiorespiratory fitness: a meta-analysis. Frontiers in Public Health, 11. [More] 
  • Sa-nguanmoo, P., Chuatrakoon, B., Pratanaphon, S., Thanagosai, J. & Sriarpon, J. (2023). Impact of Physical Activity on Pulmonary Function and Respiratory Muscle Strength in Obese Young Adults. Trends in Sciences, 20(11). [More] 
  • Pratanaphon, S., Sonsuwan, N., Chaimano, S., Chandee, S., Autkhruea, K., Sa-nguanmoo, P. et al. (2022). Obstructive Sleep Apnea Effects on Pulmonary and Respiratory Muscle Function of Obese Children and Adolescents: A Preliminary Study. Turkish Thoracic Journal, 23(2), 104-8. [More] 
  • Pipatpiboon, N., Sripetchwandee, J., Sa-nguanmoo, P., Tachaudomdach, C., Jomgeow, T., Phrommintikul, A. et al. (2022). Neutrophil-Lymphocyte Ratio (NLR) is Positively Associated with Impaired Cognitive Performance in Patients with Metabolic Syndrome. Chiang Mai University Journal of Natural Sciences, 21(1), e2022013. [More] 
  • Pratanaphon, S., Sonsuwan, N., Chaimano, S., Chandee, S., Autkhruea, K., Sa-nguanmoo, P. et al. (2022). Obstructive Sleep Apnea Effects on Pulmonary and Respiratory Muscle Function of Obese Children and Adolescents: A Preliminary Study. Turkish Thoracic Journal, 23(2), 104-108. [More] 
  • Pipatpiboon, N., Sripetchwandee, J., Sa-nguanmoo, P., Tachaudomdach, C., Jomgeow, T., Phrommintikul, A. et al. (2022). Neutrophil-Lymphocyte Ratio (NLR) is Positively Associated with Impaired Cognitive Performance inPatients with Metabolic Syndrome. Chiang Mai University Journal of Natural Sciences, 21(1). [More] 
  • Sripetchwandee, J., Pintana, H., Sa-nguanmoo, P., Boonnag, C., Pratchayasakul, W., Chattipakorn, N. et al. (2019). Comparative effects of sex hormone deprivation on the brain of insulin-resistant rats. Journal of Endocrinology, 1(aop). [More] 
  • Tanajak, P., Sa-nguanmoo, P., Sivasinprasasn, S., Thummasorn, S., Siri-Angkul, N., Chattipakorn, S. C. et al. (2018). Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury. Journal of Endocrinology, 236(2), 69-84. [More] 
  • Coleman, V., Sa-nguanmoo, P., Koenig, J., Schulz, T. J., Grune, T., Klaus, S. et al. (2018). Partial involvement of Nrf2 in skeletal muscle mitohormesis as an adaptive response to mitochondrial uncoupling. Scientific reports, 8(1), 2446. [More] 
  • Phrommintikul, A., Sa-nguanmoo, P., Sripetchwandee, J., Vathesatogkit, P., Chattipakorn, N. & Chattipakorn, S. C. (2018). FGF 21 is one of the factors associated with cognitive decline in nonelderly patients with metabolic syndrome. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 14(7), P1170-P1171. [More] 
  • Phrommintikul, A., Sa-nguanmoo, P., Sripetchwandee, J., Vathesatogkit, P., Chattipakorn, N. & Chattipakorn, S. C. (2018). Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: the different roles of FGF21. Scientific reports, 8(1), 5174. [More] 
  • Sa-nguanmoo, P., Tanajak, P., Kerdphoo, S., Jaiwongkam, T., Wang, X., Liang, G. et al. (2018). FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats. Biomedicine & Pharmacotherapy, 97, 1663-1672. [More] 
  • Ittichaicharoen, J., Apaijai, N., Tanajak, P., Sa-nguanmoo, P., Chattipakorn, N. & Chattipakorn, S. (2018). Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance. Archives of oral biology, 85, 148-153. [More] 
  • Charoenphandhu, N., Suntornsaratoon, P., Sa-nguanmoo, P., Tanajak, P., Teerapornpuntakit, J., Aeimlapa, R. et al. (2018). Dipeptidyl peptidase-4 inhibitor, vildagliptin, improves trabecular bone mineral density and microstructure in obese, insulin-resistant, pre-diabetic rats. Canadian journal of diabetes, 42(5), 545-552. [More] 
  • Sa-nguanmoo, P., Tanajak, P., Kerdphoo, S., Jaiwongkam, T., Wang, X., Liang, G. et al. (2018). FGF21 and DPP-4 inhibitor equally prevents cognitive decline in obese rats. Biomedicine and Pharmacotherapy, 97, 1663-1672. [More] 
  • Tanajak, P., Sa-nguanmoo, P., Sivasinprasasn, S., Thummasorn, S., Siri-Angkul, N., Chattipakorn, S. C. et al. (2018). Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury. Journal of Endocrinology, 236(2), 69-84. [More] 
  • Ittichaicharoen, J., Apaijai, N., Tanajak, P., Sa-nguanmoo, P., Chattipakorn, N. & Chattipakorn, S. (2018). Dipeptidyl peptidase-4 inhibitor enhances restoration of salivary glands impaired by obese-insulin resistance. Archives of Oral Biology, 85, 148-153. [More] 
  • Charoenphandhu, N., Suntornsaratoon, P., Sa-nguanmoo, P., Tanajak, P., Teerapornpuntakit, J., Aeimlapa, R. et al. (2018). Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, Improves Trabecular Bone Mineral Density and Microstructure in Obese, Insulin-Resistant, Pre-diabetic Rats. Canadian Journal of Diabetes, 42(5), 545-552. [More] 
  • Phrommintikul, A., Sa-nguanmoo, P., Sripetchwandee, J., Vathesatogkit, P., Chattipakorn, N. & Chattipakorn, S. C. (2018). Factors associated with cognitive impairment in elderly versus nonelderly patients with metabolic syndrome: The different roles of FGF21. Scientific Reports, 8(1). [More] 
  • Coleman, V., Sa-nguanmoo, P., Koenig, J., Schulz, T. J., Grune, T., Klaus, S. et al. (2018). Erratum to: Partial involvement of Nrf2 in skeletal muscle mitohormesis as an adaptive response to mitochondrial uncoupling (Scientific Reports, (2018), 8, 1, (2446), 10.1038/s41598-018-20901-4). Scientific Reports, 8(1). [More] 
  • Chattipakorn, S. C., Sa-nguanmoo, P., Tanajak, P., Kerdphoo, S., Jaiwongkam, T., Pratchayasakul, W. et al. (2017). [P3--048]: COMPARATIVE EFFECTS OF DDP4 INHIBITOR AND SGLT2 INHIBITOR ON BRAIN FUNCTION UNDER OBESE-INSULIN RESISTANT CONDITION. Alzheimer's & Dementia, 13(7S\_Part\_), P948-P949. [More] 
  • Pratchayasakul, W., Sivasinprasasn, S., Sa-nguanmoo, P., Proctor, C., Kerdphoo, S., Chattipakorn, N. et al. (2017). Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats. Menopause, 24(7), 850-858. [More] 
  • Tanajak, P., Sa-nguanmoo, P., Apaijai, N., Wang, X., Liang, G., Li, X. et al. (2017). Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats. Cardiovascular therapeutics, 35(4), e12263. [More] 
  • Sa-nguanmoo, P., Tanajak, P., Kerdphoo, S., Jaiwongkam, T., Pratchayasakul, W., Chattipakorn, N. et al. (2017). SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Toxicology and applied pharmacology, 333, 43-50. [More] 
  • Chattipakorn, S. C., Sa-nguanmoo, P., Tanajak, P., Kerdphoo, S., Jaiwongkam, T., Pratchayasakul, W. et al. (2017). COMPARATIVE EFFECTS OF DDP4 INHIBITOR AND SGLT2 INHIBITOR ON BRAIN FUNCTION UNDER OBESE-INSULIN RESISTANT CONDITION. Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 13(7), P948-P949. [More] 
  • Charoenphandhu, N., Suntornsaratoon, P., Krishnamra, N., Sa-nguanmoo, P., Tanajak, P., Wang, X. et al. (2017). Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats. Journal of bone and mineral metabolism, 35(2), 142-149. [More] 
  • Sa-nguanmoo, P., Tanajak, P., Kerdphoo, S., Jaiwongkam, T., Pratchayasakul, W., Chattipakorn, N. et al. (2017). SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats. Toxicology and Applied Pharmacology, 333, 43-50. [More] 
  • Tanajak, P., Sa-nguanmoo, P., Apaijai, N., Wang, X., Liang, G., Li, X. et al. (2017). Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats. Cardiovascular Therapeutics, 35(4). [More] 
  • Charoenphandhu, N., Suntornsaratoon, P., Krishnamra, N., Sa-nguanmoo, P., Tanajak, P., Wang, X. et al. (2017). Fibroblast growth factor-21 restores insulin sensitivity but induces aberrant bone microstructure in obese insulin-resistant rats. Journal of Bone and Mineral Metabolism, 35(2), 142-149. [More] 
  • Pratchayasakul, W., Sivasinprasasn, S., Sa-nguanmoo, P., Proctor, C., Kerdphoo, S., Chattipakorn, N. et al. (2017). Estrogen and DPP-4 inhibitor share similar efficacy in reducing brain pathology caused by cardiac ischemia-reperfusion injury in both lean and obese estrogen-deprived rats. Menopause, 24(7), 850-858. [More] 
  • Ittichaicharoen, J., Nattayapornapaijai, A., Tanajak, P., Sa-nguanmoo, P., Chattipakorn, N. & Chattipakorn, S. C. (2017). Impaired mitochondria and intracellular calcium transients in the salivary glands of obese rats. Applied Physiology, Nutrition and Metabolism, 42(4), 420-429. [More] 
  • Sivasinprasasn, S., Sa-nguanmoo, P., Pongkan, W., Pratchayasakul, W., Chattipakorn, S. C. & Chattipakorn, N. (2016). Estrogen and DPP4 inhibitor, but not metformin, exert cardioprotection via attenuating cardiac mitochondrial dysfunction in obese insulin-resistant and estrogen-deprived female rats. Menopause, 23(8), 894-902. [More] 
  • Sa-nguanmoo, P., Chattipakorn, N. & Chattipakorn, S. C. (2016). Potential roles of fibroblast growth factor 21 in the brain. Metabolic Brain Disease, 31(2), 239-248. [More] 
  • Pintana, H., Pratchayasakul, W., Sa-nguanmoo, P., Pongkan, W., Tawinvisan, R., Chattipakorn, N. et al. (2016). Testosterone deprivation has neither additive nor synergistic effects with obesity on the cognitive impairment in orchiectomized and/or obese male rats. Metabolism: Clinical and Experimental, 65(2), 54-67. [More] 
  • Pintana, H., Tanajak, P., Pratchayasakul, W., Sa-nguanmoo, P., Chunchai, T., Satjaritanun, P. et al. (2016). Energy restriction combined with dipeptidyl peptidase-4 inhibitor exerts neuroprotection in obese male rats. British Journal of Nutrition, 116(10), 1700-1708. [More] 
  • Sa-nguanmoo, P., Tanajak, P., Kerdphoo, S., Satjaritanun, P., Wang, X., Liang, G. et al. (2016). FGF21 improves cognition by restored synaptic plasticity, dendritic spine density, brain mitochondrial function and cell apoptosis in obese-insulin resistant male rats. Hormones and Behavior, 85, 86-95. [More] 
  • Tanajak, P., Sa-nguanmoo, P., Wang, X., Liang, G., Li, X., Jiang, C. et al. (2016). Fibroblast growth factor 21 (FGF21) therapy attenuates left ventricular dysfunction and metabolic disturbance by improving FGF21 sensitivity, cardiac mitochondrial redox homoeostasis and structural changes in pre-diabetic rats. Acta Physiologica, 217(4), 287-299. [More] 
  • Sivasinprasasn, S., Sa-nguanmoo, P., Pratchayasakul, W., Kumfu, S., Chattipakorn, S. C. & Chattipakorn, N. (2015). Obese-insulin resistance accelerates and aggravates cardiometabolic disorders and cardiac mitochondrial dysfunction in estrogen-deprived female rats. Age, 37(2). [More] 
  • Semaming, Y., Sripetchwandee, J., Sa-nguanmoo, P., Pintana, H., Pannangpetch, P., Chattipakorn, N. et al. (2015). Protocatechuic acid protects brain mitochondrial function in streptozotocin-induced diabetic rats. Applied Physiology, Nutrition and Metabolism, 40(10), 1078-1081. [More] 
  • Pratchayasakul, W., Sa-nguanmoo, P., Sivasinprasasn, S., Pintana, H., Tawinvisan, R., Sripetchwandee, J. et al. (2015). Obesity accelerates cognitive decline by aggravating mitochondrial dysfunction, insulin resistance and synaptic dysfunction under estrogen-deprived conditions. Hormones and Behavior, 72, 68-77. [More]